News
By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026
Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.
"These are saliva...
By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026
"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...
By Gina Maranto, Biopolitical Times guest contributor
| 12.06.2010
Since its legalization in 2002, commercial surrogacy in India has grown
into a multimillion-dollar industry, drawing couples from around the...
By Rory Harrington, DairyReporter.com | 12.06.2010
The UK stance was spelt out in a report due to go before the country’s Food Standards Agency (DSA) tomorrow...
By David Jensen, California Stem Cell Report | 12.05.2010
Is the re-election of Robert Klein as chairman of the California stem cell agency a foregone conclusion? A significant number...
By Eric Hoffman, Biopolitical Times guest contributor, Biopolitical Times | 12.02.2010
On November 16 and 17, President Obama’s Commission for the Study of Bioethical Issues
announced its draft recommendations on the...
By Nancy Scheper-Hughes, Anthropology Today | 12.01.2010
In mid-May 2010, just as the spring semester was winding to a close, I opened an email from the Executive...
By David Jensen, The Sacramento Bee | 11.28.2010
Lured by visions of nearly magical medical solutions for everything from cancer to Alzheimer's, California voters six years ago approved...
By AP, Associated Press | 11.24.2010
President Obama on Wednesday ordered a vast review to ensure the ethical treatment of people who take part in research...
By Pete Shanks, Biopolitical Times | 11.23.2010
This past weekend supplied several different examples of the way that commercial prospects affect important decisions about scientific research. What...